In the published article, there was an error regarding the equal contributions for Bram Decru and Jan Van Elslande. These authors have contributed equally to this work and share first authorship.
Bram Decru1†, Jan Van Elslande1†, Sophie Steels1, Gijs Van Pottelbergh2,3, Lode Godderis2,3,4,5, Bram Van Holm6, Xavier Bossuyt1, Johan Van Weyenbergh6‡, Piet Maes6‡ and Pieter Vermeersch1,7*‡
†These authors contributed equally to this work and share first authorship
‡These authors have contributed equally to this work and share senior authorship
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
SARS-CoV-2, COVD-19 serological testing, neutralizing antibodies, vaccination, spike, IgG, immunity, COVID-19
Citation
Decru B, Van Elslande J, Steels S, Van Pottelbergh G, Godderis L, Van Holm B, Bossuyt X, Van Weyenbergh J, Maes P and Vermeersch P (2022) Corrigendum: IgG anti-spike antibodies and surrogate neutralizing antibody levels decline faster 3 to 10 months after BNT162b2 vaccination than after SARS-CoV-2 infection in healthcare workers. Front. Immunol. 13:1098285. doi: 10.3389/fimmu.2022.1098285
Received
14 November 2022
Accepted
15 November 2022
Published
25 November 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2022
Updates
Copyright
© 2022 Decru, Van Elslande, Steels, Van Pottelbergh, Godderis, Van Holm, Bossuyt, Van Weyenbergh, Maes and Vermeersch.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Pieter Vermeersch, pieter.vermeersch@uzleuven.be
†These authors contributed equally to this work and share first authorship
‡These authors have contributed equally to this work and share senior authorship
This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.